Oxford, United Kingdom · Founded 2013 · Privately Held (backing)
Operator of a therapeutics platform intended to develop an anti-cancer therapy to improve the delivery of agents to tumors by disrupting their structure. OxSonics Therapeutics is based in Oxford, United Kingdom and was founded in 2013. Its last reported valuation was $34.6 million in Jul 2020. It has raised $30.2 million.
Last reported valuation
$34.6M
Oct 2026
Priced at
—
Total raised
$30.2M
Last round
—
No prints on record
No secondary trades in OxSonics Therapeutics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of OxSonics Therapeutics with a free account
·Watch OxSonics Therapeutics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of OxSonics Therapeutics stock.
